人机共生：脑机接口行业专家会议 20250518 Q&A 脑机接口技术的基本概念是什么？它的分类和应用场景有哪些？ 脑机接口技术是将大脑活动与外部设备直接连接，通过捕捉和解码大脑信号， 将人的意图和思维转化为计算机可以识别的指令，实现人和机器之间的交互。 脑机接口分为单向和双向两种类型。单向接口通过读取大脑信号来控制外部设 备，而双向接口则可以对大脑进行信号传输，进行刺激。主要应用场景包括神 经退行性疾病调控、瘫痪患者辅助等。 • 中国脑机接口技术发展紧随美国，但存在 1-2 年差距，主要体现在资金投 入、供应链资源和芯片开发速度上。国内企业如脑虎科技、南微医学等从 低通道产品起步，逐步追赶国际领先水平。 • 脑机接口应用场景广泛，医疗端包括疾病治疗和功能替代，消费端包括大 脑状态监测和人机交互。非侵入式手段在注意力训练、情绪调整和助眠等 领域有望率先实现规模化落地。 • 医保政策的出台旨在支持脑机接口产业发展，但湖北省制定的嵌入式脑机 接口费用指导价可能偏低。监管重点在于安全性和有效性，通过严格临床 试验驱动医疗器械开发，并逐步完善监管条例。 脑机接口技术的发展现状及市场规模如何？ 摘要 • 脑机接口技术商 ...

LEXINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced the first peer-reviewed publication of data demonstrating the ability of alkaline phosphatase (ALPL) to transport a novel AAV capsid across the blood-brain barrier (BBB). The article, titled "Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrier ...

Elon Musk's brain interface company Neurolink has officially announced they're expanding further around the globe to Abu Dhabi in the UAE. They said on X, "We're launching our first clinical trial in the Middle East at Cleveland Clinic Abu Dhabi in partnership with the Department of Health Abu Dhabi. " The UAE Prime trial explores how individuals with motor and speech impairment can use thought to control devices and communicate. The Cleveland Clinic also added, "This milestone reflects our leadership in me ...

AI-Powered, Portable Brain MRI The Swoop® Portable MR Imaging® system is driving the future of brain health. Corporate Investor Deck – May 2025 Hyperfine, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc. PROPERTY OF HYPERFINE, INC. ©2025. All rights reserved. PROPERTY OF HYPERFINE, INC. ©2025. All rights reserved. Forward-looking Statements This presentation includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigatio ...

Neumora Therapeutics (NMRA) Q1 2025 Earnings Call May 12, 2025 04:30 PM ET Company Participants Helen Rubinstein - VP-IR and Corporate CommunicationsPaul Berns - Co-Founder, Executive Chairman and Chief Executive OfficerJoshua Pinto - PresidentBill Aurora - Chief Operating & Development OfficerMichael Milligan - CFODouglas Tsao - Managing DirectorBrian Abrahams - MD & Global Sector Head - Health Care ResearchGraig Suvannavejh - Managing DirectorJohn Boyle - Biotechnology Equity Research AssociatePoorna Kann ...

Hey there, welcome to Neuropod, a channel covering all topics related to Elon Musk's brain interface company, Neuralink. My name is Ryan Tanaka, and this update episode is packed as I try to give you all the most important highlights. I'm going to share how Neurolink got FDA breakthrough device designation for their third product application, their product that will help give a voice to those who have lost the ability to speak.Then I'll share a detailed look at Neuralink's electroth threads and how they com ...

A股开盘，上证指数低开0.05%，深证成指低开0.07%，创业板指低开0.05%。军工板块延续活跃，贵金 属、脑机接口板块领跌。 ...

2025.05. 08 作者 | 一财资讯 截至今日午间收盘，沪指涨0.38%，深成指涨1.03%，创业板指涨1.74%。 盘面上看，脑机接口、光伏、铜缆高速连接、保险、军工等板块涨幅居前，PEEK材料、大豆、钢铁 等板块走弱。 个股涨多跌少，全市场超3800只个股上涨。 | 全A | 涨 3834 | 平 219 | 跌 1355 | A股成 | | --- | --- | --- | --- | --- | | 序号 代码 | 名称 | 现价 | 涨跌 | 涨跌幅 | | 1 | 000001 上证指数 | 3355.26 | 12.60 | 0.38% | | 2 | 399001 深证成指 | 10207.71 | 103.58 | 1.03% | | 3 | 899050 北证50 | 1369.52 | 1.95 | 0.14% | | 4 | 881001 万得全A | 5108.98 | 36.67 | 0.72% | | 5 | 000688 科创50 | 1027.29 | -2.90 -0.28% | | | 6 | 399006 创业板指 | 2031.22 | 34.71 1.74% ...

Core Insights - Firefly Neuroscience, Inc. has acquired Evoke Neuroscience, Inc., marking a significant step towards developing a proprietary foundation model of the human brain using its FDA-cleared Brain Network Analytics (BNA™) technology [1][2]. Company Overview - Firefly is an AI company focused on improving brain health outcomes for patients with neurological and mental disorders, utilizing its BNA™ technology for diagnostics and treatment monitoring [3][4]. - The company has built a comprehensive database of brain wave tests and secured patent protection over the past 15 years, now targeting pharmaceutical companies and medical practitioners for commercial use [3]. Acquisition Details - The acquisition of Evoke will enhance Firefly's assets, including a more than two-fold increase in proprietary brain scans, a three-fold increase in patents, and a ten-fold increase in commercial sites [2]. - The purchase terms include a total payment of $6 million, split 50% in cash and 50% in Firefly's common stock priced at $3.50 per share, along with a potential $500,000 earn-out for Evoke's investors based on future revenue performance [5]. Technological Synergies - The integration of Evoke's technologies is expected to create significant technological, clinical, and commercial synergies, enhancing Firefly's capabilities in brain health assessment [2]. - Firefly's BNA™ technology utilizes AI and machine learning on a proprietary database of over 17,000 patients, providing comprehensive insights into brain function and improving diagnostic accuracy for mental and cognitive disorders [4]. Market Position - Firefly possesses the largest known proprietary database of over 180,000 standardized EEG/ERP assessment records and has 27 granted patents, positioning the company strongly in the brain health technology market [5].

This brain chip is the future of learning because the way you gain knowledge today is broken. Sitting in front of a teacher who hates their life and only read the textbook last night is not only exhausting but also plain boring. You're bound to forget what you learned in school.Your memory is like Swiss cheese with holes in random places just rotting away. But it doesn't have to be that way. It won't always be that way.Envision yourself with a Neuralink brain chip. Now you have perfect recall, infinite memo ...